Dr. Lukose Simon Vadakara, MD

Dr. Vadakara practices at Capital Health Regional Medical Center in Trenton, New Jersey, part of Capital Health System.

Dr. Vadakara's NPI, 1255340345, was assigned on August 7, 2006. Dr. Vadakara holds New Jersey license MA69469.

Dr. Vadakara's primary practice is Capital Health Regional Medical Center, at 750 Brunswick Ave, Trenton, NJ 08638 in Mercer County. The practice phone is (609) 394-6000.

Dr. Vadakara's primary practice is Capital Health Regional Medical Center in Trenton, New Jersey, part of Capital Health System. Dr. Vadakara is also affiliated with Capital Health Medical Center - Hopewell. The medical group on file is Capital Health Medical Group. Dmand AI also links Dr. Vadakara to 1 more hospital, 3 skilled nursing facilities, 1 physician office, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vadakara practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Vadakara's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Vadakara is licensed in New Jersey.

CMS data shows 429 Medicare services from Dr. Vadakara across 8 procedure codes in 2024, for 168 Medicare patients. Medicare paid $36,796 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Dr. Vadakara in 2024. The largest group is 75 to 84, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vadakara's median patient age at 70, with 48% women.

In 2024, Dr. Vadakara wrote 11,145 Medicare Part D claims for 677 patients. 83% of them were for generic drugs. CMS names the drug for 10,164 of them, across 188 drugs with 11 or more claims each, at $1,028,412 in total drug cost. In 2023, CMS named 9,077 claims across 175 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Vadakara for performance year 2024, reported through an alternative payment model (APM). Dr. Vadakara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vadakara as offering telehealth. CMS counts 14 procedures of removal of nail tissue by Dr. Vadakara, more than 59% of the clinicians it reports for that procedure.

CMS Open Payments shows 440 general payments to Dr. Vadakara from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $692.